Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype

NCT00808184 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT00808184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00808184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype
Lead sponsor
National University Hospital, Singapore
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2010
Completion date
February 29, 2012
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor